Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

Technology

The FDA recently cleared Boston Scientific Corp.’s PROMUS Everolimus-Eluting Coronary Stent System and Abbott Vascular’s ...

Home September 03, 2008
Home
News

September 2, 2008 - The safety debate about drug-eluting stents (DES) is still ongoing and in these times of uncertainty ...

Home September 02, 2008
Home
News

September 2, 2008 – Boston Scientific Corp. today announced positive one-year results from the European and ...

Home September 01, 2008
Home
News

September 2, 2008 - Data from the landmark SYNTAX trial indicates patients with very complex coronary artery disease can ...

Home September 01, 2008
Home
News

September 2, 2008 - Patients with both diabetes and advanced blockages in at least three heart vessels will find good ...

Home September 01, 2008
Home
News

August 29, 2008 - The Vascular Medtronic Talent Thoracic Stent Graft System (VALOR) is a safe and effective endovascular ...

Home August 28, 2008
Home
News

August 28, 2008 – In patients with diabetes, the CYPHER Sirolimus-eluting coronary stent outperformed the Taxus stent ...

Home August 27, 2008
Home
Technology

Stentys, a French-based company, will feature its bifurcated stent at TCT 2008.


The patent-pending bifurcated stent is ...

Home August 26, 2008
Home
News

August 27, 2008 - Cordis Corp. today said it received CE mark approval to market the CYPHER SELECT Plus Sirolimus ...

Home August 26, 2008
Home
Technology

Medtronic Inc. will feature its FDA-cleared Talent Abdominal Stent Graft on the CoilTrac Delivery System for the ...

Home August 25, 2008
Home
Technology

Medtronic Inc. recently announced the initiation of the first investigational sites in the U.S. to participate in ...

Home August 25, 2008
Home
News

August 26, 2008 - In a major landmark for advanced interventional technology to treat aortic disease, the Zenith Branch ...

Home August 25, 2008
Home
News

August 25, 2008 - A study conducted by the Cardiovascular Research Institute, Washington Hospital Center, Washington, D ...

Home August 24, 2008
Home
News

August 14, 2008 - Boston Scientific and FDA today informed healthcare professionals and patients of the Class I Recall ...

Home August 13, 2008
Home
News

August 11, 2008 - Flexible Stenting Solutions Inc. said today a physician at Auckland City Hospital in New Zealand ...

Home August 10, 2008
Home
Subscribe Now